RETRACTION: SLC1A3 Promotes Gastric Cancer Progression via the PI3K/AKT Signalling Pathway
DOI: https://doi.org/10.1111/jcmm.18568
Abstract:Xu L, Chen J, Jia L, Chen X, Moumin FA, Cai J. SLC1A3 Promotes Gastric Cancer Progression via the PI3K/AKT Signalling Pathway. Journal of Cellular and Molecular Medicine 2020;24(24):14392-14404. https://doi.org/10.1111/jcmm.16060 The above article, published online on 3 November 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan N. Constantinescu; the Foundation for Cellular and Molecular Medicine; and John Wiley & Sons Ltd. The retraction has been agreed due to concerns raised by third parties. Specifically, image elements of Figure 6G were found to have been previously published in a different scientific context.1 The corresponding author stated that a third-party company partially generated the data presented in the article and suggested there may have been mishandling of the data. Additionally, the article mentions use of the unverifiable/unknown cell line GSE-1 and presents results from the cell line MKN-28, reported as misidentified by the Japanese Collection of Research Bioresources (JCRB) Cell Bank of the National Institutes of Biomedical Innovation, Health and Nutrition (https://cellbank.nibiohn.go.jp/). Therefore, the editors consider the conclusions of this article to be invalid. The authors have been informed of the decision of retraction. [1] Pang X, Li R, Shi D, Pan X, Ma C, Zhang G, Mu C, Chen W. Knockdown of Rhotekin 2 expression suppresses proliferation and induces apoptosis in colon cancer cells. Oncol Lett. 2017;14(6):8028-8034. https://doi.org/10.1111/jcmm.16060.